TCGA

7 results.

January 2, 2025 New resource available to help scientists better classify cancer subtypes

GRAND RAPIDS, Mich. (Jan. 2, 2025) — A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples…

April 4, 2018 Van Andel Research Institute scientists help redefine how cancer is categorized

GRAND RAPIDS, Mich. (April 5, 2018) — Van Andel Research Institute (VARI) announced today that the work of its scientists is featured in 27…

April 4, 2018 Comprehensive atlas redefines gastrointestinal cancers

Scientists now have a powerful new resource for developing better treatments for common cancers of the esophagus, stomach, colon and rectum, collectively known as gastrointestinal…

April 1, 2018 Scientists discover new method for measuring cellular age
Nature Genetics paper shows cells begin losing important DNA marks in utero

GRAND RAPIDS, Mich., and LOS ANGELES (April 2, 2018) — A team led by scientists at Van Andel Research Institute (VARI) and

VAI DEFAULT HEADER
January 3, 2017 Comprehensive study of esophageal cancer reveals several molecular subtypes, provides new insight into increasingly prevalent disease

The Cancer Genome Atlas Research Network recommends clinical trials organizers and drug manufacturers focus on newly discovered molecular subtypes

GRAND RAPIDS, Mich. (Jan. 4,…

November 16, 2016 Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis

GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from the National Cancer…

November 4, 2015 TCGA findings provide molecular background for second most common kidney cancer

GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have…